Israeli biotech company begins trial for cancer immuno-oncology solution
The company’s product, NTX1088, blocks the harmful overexpression of PVR proteins, which occurs in tumors caused by lung, breast, throat and other cancers.
Source: jpost.com
Page 14 - Focus Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Focus Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Focus Fund Today - Breaking & Trending Today
Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.
Source: seekingalpha.com
Billionaire Stanley Druckenmiller is Selling These 10 Stocks
In this article, we discuss the 10 stocks that billionaire Stanley Druckenmiller is selling.
Source: insidermonkey.com
Fund Manager of the Year Awards 2022 winners
Investment Week is pleased to congratulate the winners of the Fund Manager of the Year Awards 2022.
Source: investmentweek.co.uk
Monsters of Rock: Banks don't want to finance coal but Bowen finds a way
Monsters of Rock: Banks don’t want to finance coal but Bowen finds a way
Source: stockhead.com.au